Luengo-Fernandez, R., Penz, E., Dobson, M., Psallidas, I., Nunn, A., Maskell, N., & Rahman, N. (2019). Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial. European Respiratory Society Publications.
Chicago-Zitierstil (17. Ausg.)Luengo-Fernandez, R., E. Penz, M. Dobson, I. Psallidas, A. Nunn, N. Maskell, und N. Rahman. Cost-effectiveness of Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection: Evidence from the MIST2 Randomised Controlled Trial. European Respiratory Society Publications, 2019.
MLA-Zitierstil (9. Ausg.)Luengo-Fernandez, R., et al. Cost-effectiveness of Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection: Evidence from the MIST2 Randomised Controlled Trial. European Respiratory Society Publications, 2019.